全髋关节置换术后使用SF-6D确定健康相关生活质量结局
该研究评估了7家机构188例初次全髋关节置换术患者(平均年龄69岁,平均BMI 28.8 kg/m²),术前及术后6个月、1、2、3、5年采用SF-6D测量健康相关生活质量。SF-6D评分在所有时间点较术前显著改善(p<0.05),效应量均大于0.8,且与下肢活动量表和Harris髋关节评分改善显著正相关(p<0.01)。
要点
- 全髋关节置换术后SF-6D评分在所有随访时间点较术前显著改善(p<0.05)。
- 效应量在6个月为1.27、1年为1.30、2年为1.07、3年为1.08、5年为1.05,均显示良好临床相关性。
- SF-6D评分改善与下肢活动量表和Harris髋关节评分改善在所有时间点显著正相关(p<0.01)。
核心结论
- 全髋关节置换术后SF-6D评分与功能结局相关并具有临床相关性(由效应量证明);作者认为将该简便易用的测量工具纳入全髋关节置换术后患者评估将有助于未来成本-效用分析。
研究设计与样本
- 评估7家机构188例初次全髋关节置换术患者,平均年龄69岁(范围47至88岁),平均体重指数28.8 kg/m²(范围19.8至38.9 kg/m²);从SF-36评分获得SF-6D值,采用效应量判定价值变化的临床相关性,效应量0.2至0.5为小、0.6至0.8为中等、>0.8为大;采用下肢活动量表和Harris髋关节评分评估临床相关性;术前及术后6个月和1、2、3、5年进行评估;证据等级为治疗性IV级。
主要发现
- SF-6D评分较术前改善并在所有时间点达到显著(p<0.05)。
- 效应量显示至最新随访均具有良好临床相关性:6个月为1.27、1年为1.30、2年为1.07、3年为1.08、5年为1.05。
- 下肢活动量表较术前改善,6个月为1.8分、1年为2.0分、2年为1.8分、3年为1.5分、5年为1.6分。
- Harris髋关节评分改善至术后6个月38分、1年40分、2年38分、3年39分、5年41分。
- 下肢活动量表和Harris髋关节评分的改善在所有时间点与SF-6D评分显著正相关(p<0.01)。
关键数值与推荐
- 效应量判定标准:0.2至0.5为小、0.6至0.8为中等、>0.8为大。
- SF-6D评分较术前改善在所有时间点达显著(p<0.05)。
- 下肢活动量表和Harris髋关节评分改善与SF-6D评分在所有时间点显著正相关(p<0.01)。
临床怎么用
- 作者认为将这一简便易用的测量工具纳入全髋关节置换术后患者评估将有助于未来成本-效用分析。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Following total hip arthroplasty, patients' perception of their postoperative improvement and health plays a large role in satisfaction with and success of the surgical procedure. The Short Form-6D (SF-6D) is a health-related quality-of-life measure that assigns numerical value to the perception of patients' own health. The purpose was to determine SF-6D values of patients after total hip arthroplasty, to determine whether score changes were clinically relevant, and to compare these with postoperative functional improvements. METHODS: We evaluated 188 patients who underwent primary total hip arthroplasty at 7 institutions and who had a mean age of 69 years (range, 47 to 88 years) and a mean body mass index of 28.8 kg/m (range, 19.8 to 38.9 kg/m). The SF-6D values were obtained from patients' SF-36 scores, and clinical relevance of value changes was determined using effect size. Using previous research, effect sizes were considered small between 0.2 and 0.5, moderate between 0.6 to 0.8, and large at >0.8. Clinical correlation was assessed using the Lower-Extremity Activity Scale and Harris hip scores. Patients were assessed preoperatively and postoperatively at 6 months and 1, 2, 3, and 5 years. RESULTS: The SF-6D scores improved from preoperatively and achieved significance (p < 0.05) at all points. The effect size demonstrated good clinical relevance up to the latest follow-up: 1.27 at 6 months, 1.30 at 1 year, 1.07 at 2 years, 1.08 at 3 years, and 1.05 at 5 years. The Lower-Extremity Activity Scale improved at all follow-up points from preoperatively to 1.8 at 6 months, 2.0 at 1 year, 1.8 at 2 years, 1.5 at 3 years, and 1.6 points at 5 years. The Harris hip score improved to 38 points at 6 months, 40 points at 1 year, 38 points at 2 years, 39 points at 3 years, and 41 points at 5 years postoperatively. The improvements in the Lower-Extremity Activity Scale and the Harris hip score significantly positively correlated (p < 0.01) with the SF-6D scores at all time points. CONCLUSIONS: SF-6D scores after total hip arthroplasty correlate with functional outcomes and have clinical relevance, as demonstrated by their effect size. Incorporating this straightforward and easy-to-use measurement tool when evaluating patients following total hip arthroplasty will facilitate future cost-utility analyses. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.
引用
- Elmallah RK, Chughtai M, Adib F, et al. Determining Health-Related Quality-of-Life Outcomes Using the SF-6D Following Total Hip Arthroplasty. J Bone Joint Surg Am. 2017. PMID: 28291182. doi:10.2106/JBJS.15.01351
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。